Business · 22/09/2022

FDA Clears NIX (Permethrin) 1% Topical Creme Rinse for Nonprescription Use, Cites Misbranding Concerns

The FDA has determined that prescription NIX (permethrin) 1% topical creme rinse was not withdrawn from sale due to safety or effectiveness concerns, but its nonprescription use may be misbranded under FDA regulations, and the agency will not approve abbreviated new drug applications referencing the product.